Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human
1 Research Institute GROW 2 Department of Pathology 3 Department of Obstetrics and Gynaecology, University Hospital Maastricht/University Maastricht, Maastricht, The Netherlands 4 Department of Molecular Diagnostics, Philips Research, High Tech Campus 11, 5656 AE Eindhoven, The Netherlands
5 Correspondence address. Department of Pharmacology, Organon Biosciences, Molenstraat 110, Oss, The Netherlands. Tel: +31-412-669874; Fax: +31-412-669874; E-mail. patrick.groothuis{at}organon.com
To date, research into the biological processes and molecular mechanisms associated with endometrial receptivity and embryo implantation has been a focus of attention, whereas the complex events that occur in the human endometrium during the menstrual and proliferative phase under the influence of estrogen have received little attention. The objective of this review is to provide an update of our current understanding of the actions of estrogen on both human and rodent endometrium, with special emphasis on the regulation of uterine growth and cell proliferation, and the value of global gene expression analysis, in increasing understanding of these processes.
Key words: estradiol / endometrium / uterus / gene profiling / proliferation
Received on October 17, 2006; accepted on April 18, 2006
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Shao, M. Nutu, L. Karlsson-Lindahl, A. Benrick, B. Weijdegard, S. Lager, E. Egecioglu, J. Fernandez-Rodriguez, K. Gemzell-Danielsson, C. Ohlsson, et al. Downregulation of cilia-localized Il-6R{alpha} by 17{beta}-estradiol in mouse and human fallopian tubes Am J Physiol Cell Physiol, July 1, 2009; 297(1): C140 - C151. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Salama, M. W. Kamel, C. R. Diaz-Arrastia, X. Xu, T. D. Veenstra, S. Salih, S. K. Botting, and R. Kumar Effect of Tumor Necrosis Factor-{alpha} on Estrogen Metabolism and Endometrial Cells: Potential Physiological and Pathological Relevance J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 285 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Aberdeen, S. J. Wiegand, T. W. Bonagura Jr., G. J. Pepe, and E. D. Albrecht Vascular Endothelial Growth Factor Mediates the Estrogen-Induced Breakdown of Tight Junctions between and Increase in Proliferation of Microvessel Endothelial Cells in the Baboon Endometrium Endocrinology, December 1, 2008; 149(12): 6076 - 6083. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shao, M. Nutu, B. Weijdegard, E. Egecioglu, J. Fernandez-Rodriguez, E. Tallet, V. Goffin, C. Ling, and H. Billig Differences in Prolactin Receptor (PRLR) in Mouse and Human Fallopian Tubes: Evidence for Multiple Regulatory Mechanisms Controlling PRLR Isoform Expression in Mice Biol Reprod, October 1, 2008; 79(4): 748 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Fraser, H. Wilson, A. Silvestri, K. D. Morris, and S. J. Wiegand The Role of Vascular Endothelial Growth Factor and Estradiol in the Regulation of Endometrial Angiogenesis and Cell Proliferation in the Marmoset Endocrinology, September 1, 2008; 149(9): 4413 - 4420. [Abstract] [Full Text] [PDF] |
||||



